161 related articles for article (PubMed ID: 1718640)
1. Separation of self from non-self in the complement system: a role for membrane cofactor protein and decay accelerating factor.
Atkinson JP; Oglesby TJ; White D; Adams EA; Liszewski MK
Clin Exp Immunol; 1991 Oct; 86 Suppl 1(Suppl 1):27-30. PubMed ID: 1718640
[No Abstract] [Full Text] [Related]
2. Decay-accelerating factor and membrane cofactor protein.
Lublin DM; Atkinson JP
Curr Top Microbiol Immunol; 1990; 153():123-45. PubMed ID: 1688754
[No Abstract] [Full Text] [Related]
3. Membrane-associated proteins regulating the complement system: functions and deficiencies.
Schieren G; Hänsch GM
Int Rev Immunol; 1993; 10(1):87-101. PubMed ID: 7688019
[No Abstract] [Full Text] [Related]
4. Mouse complement regulatory protein Crry/p65 uses the specific mechanisms of both human decay-accelerating factor and membrane cofactor protein.
Kim YU; Kinoshita T; Molina H; Hourcade D; Seya T; Wagner LM; Holers VM
J Exp Med; 1995 Jan; 181(1):151-9. PubMed ID: 7528766
[TBL] [Abstract][Full Text] [Related]
5. [Complement regulatory proteins].
Miyagawa S
Nihon Rinsho; 2005 Apr; 63 Suppl 4():274-8. PubMed ID: 15861668
[No Abstract] [Full Text] [Related]
6. Functional domains, structural variations and pathogen interactions of MCP, DAF and CR1.
Hourcade D; Liszewski MK; Krych-Goldberg M; Atkinson JP
Immunopharmacology; 2000 Aug; 49(1-2):103-16. PubMed ID: 10904110
[TBL] [Abstract][Full Text] [Related]
7. Human CD46 rather than CD55 is a key element in protection against complement activation in vitro.
van Dixhoorn MG; Dekker S; Janssen RW; Verbakel CA; Grosveld F
Transplant Proc; 2000 Aug; 32(5):916-8. PubMed ID: 10936272
[No Abstract] [Full Text] [Related]
8. A soluble chimeric complement inhibitory protein that possesses both decay-accelerating and factor I cofactor activities.
Higgins PJ; Ko JL; Lobell R; Sardonini C; Alessi MK; Yeh CG
J Immunol; 1997 Mar; 158(6):2872-81. PubMed ID: 9058824
[TBL] [Abstract][Full Text] [Related]
9. [Self- and non-self recognition mechanism via the complement system].
Okada N
Nihon Rinsho; 2005 Apr; 63 Suppl 4():279-83. PubMed ID: 15861669
[No Abstract] [Full Text] [Related]
10. Phospholipid-anchored and transmembrane versions of either decay-accelerating factor or membrane cofactor protein show equal efficiency in protection from complement-mediated cell damage.
Lublin DM; Coyne KE
J Exp Med; 1991 Jul; 174(1):35-44. PubMed ID: 1711565
[TBL] [Abstract][Full Text] [Related]
11. Human regulator of complement activation (RCA) gene family proteins and their relationship to microbial infection.
Seya T
Microbiol Immunol; 1995; 39(5):295-305. PubMed ID: 7565169
[No Abstract] [Full Text] [Related]
12. Decay accelerating factor (CD55).
Nicholson-Weller A
Curr Top Microbiol Immunol; 1992; 178():7-30. PubMed ID: 1385047
[No Abstract] [Full Text] [Related]
13. Immune evasion of tumor cells using membrane-bound complement regulatory proteins.
Gorter A; Meri S
Immunol Today; 1999 Dec; 20(12):576-82. PubMed ID: 10562709
[TBL] [Abstract][Full Text] [Related]
14. Expression of a hybrid complement regulatory protein, membrane cofactor protein decay accelerating factor on Chinese hamster ovary. Comparison of its regulatory effect with those of decay accelerating factor and membrane cofactor protein.
Iwata K; Seya T; Ariga H; Nagasawa S
J Immunol; 1994 Apr; 152(7):3436-44. PubMed ID: 7511647
[TBL] [Abstract][Full Text] [Related]
15. Protection of mammalian cells from complement-mediated lysis by transfection of human membrane cofactor protein and decay-accelerating factor.
Oglesby TJ; White D; Tedja I; Liszewski K; Wright L; Van den Bogarde J; Atkinson JP
Trans Assoc Am Physicians; 1991; 104():164-72. PubMed ID: 1726964
[No Abstract] [Full Text] [Related]
16. The regulation of the complement system: insights from genetically-engineered mice.
Turnberg D; Botto M
Mol Immunol; 2003 Sep; 40(2-4):145-53. PubMed ID: 12914820
[TBL] [Abstract][Full Text] [Related]
17. Effect of transfected MACIF (CD59) on complement-mediated swine endothelial cell lysis, compared with those of membrane cofactor protein (CD46) and decay-accelerating factor (CD55).
Miyagawa S; Shirakura R; Nakata S; Izutani H; Matsuda H; Iwata K; Nagasawa S; Terado A; Hatanaka M; Matsumoto M
Transplant Proc; 1995 Feb; 27(1):328-9. PubMed ID: 7533401
[No Abstract] [Full Text] [Related]
18. Paroxysmal nocturnal hemoglobinuria and glycosyl phosphatidylinositol anchored proteins that regulate complement.
Parker CJ
Clin Exp Immunol; 1991 Oct; 86 Suppl 1(Suppl 1):36-42. PubMed ID: 1718642
[No Abstract] [Full Text] [Related]
19. Relative roles of hCD46 and hCD55 in the regulation of hyperacute rejection.
Verbakel CA; Bonthuis F; Eerhart SE; van Dixhoorn M; Grosveld F; Marquet RL; IJzermans JN
Transplant Proc; 2000 Aug; 32(5):903-4. PubMed ID: 10936266
[No Abstract] [Full Text] [Related]
20. Structure and function of decay accelerating factor CD55.
Nicholson-Weller A; Wang CE
J Lab Clin Med; 1994 Apr; 123(4):485-91. PubMed ID: 7511675
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]